CHRISTIANA STAMOULIS - Corporate Board Profile

HOLOGIC INC

Filing Date	Source Excerpt
2014-01-15	Christiana Stamoulis (2)(3) 43 Director 2011 (3) Member of our Audit Committee (2) Member of our Corporate Development Committee Christiana Stamoulis has been one of our directors since November 1, 2011.
2015-01-16	Christiana Stamoulis Director Since: 2011 Age: 44 Ms. Stamoulis has been one of our directors since November 1, 2011. In January 2015, Ms. Stamoulis was appointed Chief Financial Officer and Head of Corporate Development at Unum Therapeutics. Prior to Unum, she was an independent advisor to biopharmaceutical companies from January 2014 to December 2014. Prior to that, Ms. Stamoulis served as Senior Vice President of Corporate Strategy and Business Development at Vertex Pharmaceuticals Incorporated, from 2009 until December 2013. Ms. Stamoulis joined Vertex in 2009 with approximately 15 years of experience in the investment banking and management consulting industries where she advised global pharmaceutical and biotechnology companies on strategic and corporate finance decisions. Prior to joining Vertex, she was a Managing Director in the Investment Banking division of Citigroup from 2006 to 2009 where she led the building of the firm’s U.S. Life Sciences investment banking practice. Prior to her role at Citigroup, she was at Goldman, Sachs & Co. where she spent the majority of her investment banking career. Ms. Stamoulis started her career as a strategy consultant at The Boston Consulting Group. Ms. Stamoulis holds a Bachelor of Science degree in Economics and a Bachelor of Science degree in Architecture from the Massachusetts Institute of Technology (MIT). Additionally, she holds a Master of Business Administration from the MIT Sloan School of Management where she focused on Applied Economics and Finance. Ms. Stamoulis’s solid foundation in strategic development coupled with extensive experience in executing initiatives for growth in the medical products field and related industries enable her to provide valuable insights to the Board.
2016-01-20	Christiana Stamoulis Age: 45 Director Since: 2011 Current Committee Membership: Audit, Corporate Development 2015 Director Compensation Table: Total $250,991
2017-01-20	Christiana Stamoulis CFO and Head of Corporate Development Unum Therapeutics Age: 46 Director Since: 2011 Current Committee Membership: Audit and Finance 2016 Director Compensation Table: Fees Earned or Paid in Cash: $73,000, Stock Awards: $87,469, Option Awards: $87,492, Total: $247,961
2018-01-26	Ms. Stamoulis has been a director since November 2011. In January 2015, Ms. Stamoulis was appointed Chief Financial Officer and Head of Corporate Development at Unum Therapeutics. The Audit and Finance Committee is responsible for assisting our Board in the oversight of our financial reporting process. The following table sets forth the compensation paid to our non-employee directors for service on our Board during the fiscal year ended September 30, 2017.
2019-01-18	Christiana Stamoulis Executive Vice President and Chief Financial Officer Incyte Corporation (effective February 11, 2019) Age: 48 Director Since: 2011 Committees: Audit and Finance 2018 Director Compensation Table: Total $266,287
2020-01-22	Christiana Stamoulis • Independent Executive Vice President and Chief Financial Officer, Incyte Corporation. Age 49, Director Since 2011. Committees: Audit and Finance. 2019 Director Compensation Table: Total $279,984.
2021-01-21	Christiana Stamoulis (Independent) Executive Vice President and Chief Financial Officer Incyte Corporation Age 50 Director Since 2011 Committees: Audit and Finance. Compensation: $279,994.
2022-01-20	Christiana Stamoulis (Independent) Executive Vice President and Chief Financial Officer Incyte Corporation Age 51 Director Since 2011 Committees • Audit and Finance 2021 Director Compensation Table Christiana Stamoulis Fees Earned or Paid in Cash ($) 97,500 Stock Awards ($) 104,982 Option Awards ($) 104,992 Total ($) 307,474
2023-01-19	Christiana Stamoulis (Independent) Executive Vice President and Chief Financial Officer Incyte Corporation Age 52 Director Since 2011 Committees • Audit and Finance 2022 Director Compensation Table: Fees Earned or Paid in Cash $90,000 Stock Awards $109,988 Option Awards $109,989 Total $309,977
2024-01-18	Christiana Stamoulis (Independent) Executive Vice President and Chief Financial Officer Incyte Corporation Age 53 Director Since 2011 Audit and Finance 2023 Director Compensation Table: Fees Earned or Paid in Cash $90,000, Stock Awards $114,988, Option Awards $114,975, Total $319,963
2025-01-16	Christiana Stamoulis (Independent) Executive Vice President and Chief Financial Officer Incyte Corporation Age 54, Director Since 2011. Committees: Audit and Finance. 2024 Director Compensation Table shows total compensation of $329,952.